Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E V Schmidt

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Research Communications in Molecular Pathology and Pharmacology|September 1, 1995
Down-regulation of c-myc mRNA after completion of liver regeneration in transgenic mice expressing hepatocyte growth factor in liverG Shiota, H Kawasaki, T Nakamura, et al.
Research Communications in Molecular Pathology and Pharmacology|September 1, 1994
Inhibitory effect of hepatocyte growth factor against FaO hepatocellular carcinoma cells may be associated with changes of intracellular signalling pathways mediated by protein kinase CG Shiota, H Kawasaki, T Nakamura, et al.
Zhurnal Nevropatologii I Psikhiatrii Imeni S.S. Korsakova (Moscow, Russia : 1952)|January 1, 1973
[Regularities in the dissemination of emboli in the superficial vessels of the brain in repeated experimental embolism]E V Schmidt, T V Riasina, T D Toporkova
Molecular and Cellular Biology|August 1, 1990
The cytomegalovirus enhancer: a pan-active control element in transgenic miceE V Schmidt, G Christoph, R Zeller, et al.
Research Communications in Molecular Pathology and Pharmacology|October 1, 1995
Characterization of double transgenic mice expressing hepatocye growth factor and transforming growth factor alphaG Shiota, H Kawasaki, T Nakamura, et al.
Research Communications in Molecular Pathology and Pharmacology|January 1, 1996
Inhibitory effect of hepatocyte growth factor on metastasis of hepatocellular carcinoma in transgenic miceG Shiota, H Kawasaki, T Nakamura, et al.
Research Communications in Molecular Pathology and Pharmacology|August 1, 1994
Assessment of in vitro growth potential of hepatocytes expressing hepatocyte growth factor in an autocrine fashionG Shiota, H Kawasaki, T Nakamura, et al.
Canadian Journal of Physiology and Pharmacology|October 1, 1991
cis-dominance of rat atrial natriuretic factor gene regulatory sequences in transgenic miceC E Seidman, E V Schmidt, J G Seidman
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1988
Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: a pre-B-cell lymphoma modelE V Schmidt, P K Pattengale, L Weir, et al.
Hepatology (Baltimore, Md.)|April 1, 1994
Hepatocyte growth factor in transgenic mice: effects on hepatocyte growth, liver regeneration and gene expressionG Shiota, T C Wang, T Nakamura, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Research Communications in Molecular Pathology and Pharmacology|September 1, 1995
Down-regulation of c-myc mRNA after completion of liver regeneration in transgenic mice expressing hepatocyte growth factor in liverG Shiota, H Kawasaki, T Nakamura, et al.
Research Communications in Molecular Pathology and Pharmacology|September 1, 1994
Inhibitory effect of hepatocyte growth factor against FaO hepatocellular carcinoma cells may be associated with changes of intracellular signalling pathways mediated by protein kinase CG Shiota, H Kawasaki, T Nakamura, et al.
Zhurnal Nevropatologii I Psikhiatrii Imeni S.S. Korsakova (Moscow, Russia : 1952)|January 1, 1973
[Regularities in the dissemination of emboli in the superficial vessels of the brain in repeated experimental embolism]E V Schmidt, T V Riasina, T D Toporkova
Molecular and Cellular Biology|August 1, 1990
The cytomegalovirus enhancer: a pan-active control element in transgenic miceE V Schmidt, G Christoph, R Zeller, et al.
Research Communications in Molecular Pathology and Pharmacology|October 1, 1995
Characterization of double transgenic mice expressing hepatocye growth factor and transforming growth factor alphaG Shiota, H Kawasaki, T Nakamura, et al.
Research Communications in Molecular Pathology and Pharmacology|January 1, 1996
Inhibitory effect of hepatocyte growth factor on metastasis of hepatocellular carcinoma in transgenic miceG Shiota, H Kawasaki, T Nakamura, et al.
Research Communications in Molecular Pathology and Pharmacology|August 1, 1994
Assessment of in vitro growth potential of hepatocytes expressing hepatocyte growth factor in an autocrine fashionG Shiota, H Kawasaki, T Nakamura, et al.
Canadian Journal of Physiology and Pharmacology|October 1, 1991
cis-dominance of rat atrial natriuretic factor gene regulatory sequences in transgenic miceC E Seidman, E V Schmidt, J G Seidman
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1988
Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: a pre-B-cell lymphoma modelE V Schmidt, P K Pattengale, L Weir, et al.
Hepatology (Baltimore, Md.)|April 1, 1994
Hepatocyte growth factor in transgenic mice: effects on hepatocyte growth, liver regeneration and gene expressionG Shiota, T C Wang, T Nakamura, et al.
Pageof 6